Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arrhythmia Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06324682
What this trial is testing

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

Who this might be right for
Arrhythmias, CardiacAtrioventricular BlockReduced Systolic Function+22 more
University Hospital of Ferrara 8,400
Large-scale testing (Phase 3)WithdrawnNCT02582190
What this trial is testing

COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF

Who this might be right for
Atrial Fibrillation
Elpen Pharmaceutical Co. Inc.
Post-approval studies (Phase 4)Study completedNCT06448624
What this trial is testing

Biomarkers & Infection After Prophylactic Antibiotic in Cardiac Implantable Electronic Device Implantation

Who this might be right for
Heart BlockCIED Related InfectionCIED-related Infections+2 more
Universitas Diponegoro 60
Large-scale testing (Phase 3)Ended earlyNCT01570530
What this trial is testing

Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery

Who this might be right for
Atrial Fibrillation
Fundación General Universidad de Valladolid 90
Not applicableStudy completedNCT02687867
What this trial is testing

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 56,039
Large-scale testing (Phase 3)Study completedNCT04607122
What this trial is testing

Prevention of Atrial Fibrillation by Low-dose Landiolol Administration After Cardiac Surgery

Who this might be right for
Atrial FibrillationCardiac Surgery
CMC Ambroise Paré 400
Not applicableStudy completedNCT02428140
What this trial is testing

Post-Embolic Rhythm Detection With Implantable Versus External Monitoring

Who this might be right for
StrokeAtrial FibrillationArrhythmias, Cardiac
University of Alberta 300
Not applicableUnknownNCT05140343
What this trial is testing

Mobile Electrocardiogram Monitoring for Detecting Arrhythmias in Children

Who this might be right for
Arrhythmias, CardiacChildren, OnlyCongenital Heart Disease+2 more
Centro Medico Teknon 84
Post-approval studies (Phase 4)Study completedNCT04069078
What this trial is testing

Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section

Who this might be right for
BradycardiaSpinal Anesthetics Causing Adverse Effects in Therapeutic UseCesarean Section Complications
Assiut University 173
Post-approval studies (Phase 4)Not Yet RecruitingNCT07237308
What this trial is testing

BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis

Who this might be right for
StrokeIschemicAtrial Fibrillation+2 more
Yonsei University 586
Not applicableStudy completedNCT03854149
What this trial is testing

Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study

Who this might be right for
Congenital Heart DiseaseAtrial ArrhythmiaThromboembolism+1 more
AHEPA University Hospital 218
Not applicableLooking for participantsNCT05367037
What this trial is testing

Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval

Who this might be right for
Sinus Node DiseaseAtrioventricular; Block, Second Degree (Types I and II)
Quovadis Associazione 640
Post-approval studies (Phase 4)Ended earlyNCT00861237
What this trial is testing

Homeopathy for Prevention of Atrial Fibrillation After Aortocoronary Bypass Surgery

Who this might be right for
Atrial Fibrillation
Medical University of Vienna 12
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Large-scale testing (Phase 3)Study completedNCT00402363
What this trial is testing

Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

Who this might be right for
Fibrillation, Atrial
GlaxoSmithKline 663
Not applicableLooking for participantsNCT03642509
What this trial is testing

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
University of Aarhus 750
Not applicableStudy completedNCT00198614
What this trial is testing

Carvedilol Versus Metoprolol for the Prevention of Atrial Fibrillation After Off-Pump Coronary Bypass Surgery

Who this might be right for
Coronary DiseaseAtrial Fibrillation
Ministry of Health, Labour and Welfare, Japan 650
Not applicableUnknownNCT01522911
What this trial is testing

Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage

Who this might be right for
Atrial FibrillationStroke PreventionLeft Atrial Appendage
University of Leipzig 50
Not applicableUnknownNCT02743416
What this trial is testing

Systematic NT-proBNP and ECG Screening for Atrial Fibrillation Among 75 Year Old Subjects in the Region of Stockholm, Sweden - STROKESTOP II

Who this might be right for
Atrial FibrillationStroke
Karolinska University Hospital 6,868
Not applicableStudy completedNCT02433366
What this trial is testing

Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,213
Next Page